Partner with Indero for Site Selection & Management
Indero is a dual-focus CRO for dermatology and rheumatology clinical trials that identifies, qualifies, and selects the most suitable sites for successful studies.
Strategic site selection for dermatology and rheumatology clinical trials, based on relevant experience in your indication, positive indicators in efficacy assessments, and proven recruitment track records.
(1) Site List
(2) Site Outreach
(3) Site Qualification Visit (SQV)
(4) Site Selection
Sites with high-quality indicators in efficacy assessments and overall study performance.
Senior Vice President, Clinical Development
Ventyx Biosciences, Inc.
“. . . From the initial synopsis development to the final stages of study conduct, the synergy between our teams was palpable and was underpinned by Indero’s strong relationships with sites, investigators, and KOLs. . .”
With customized and consolidated outreach processes, Indero offers efficient and expedited site selection timelines. Here’s what makes our site selection and management services so successful:
Indero is a dual-focus CRO for dermatology and rheumatology clinical trials that identifies, qualifies, and selects the most suitable sites for successful studies.
Scientific discipline. Operational efficiency. Clinical development expertise. Our site selection and management services provide the rigorous foundation, quality data, and expertise dermatology and rheumatology studies need to ensure effective execution and on-time delivery.
“My work experience with Indero has been very positive. Their monitoring support has been crucial in achieving our research goals. So far, this partnership is a true success story. Their professionalism and expertise are commendable.”
Copernicus Medical Center, Gdansk
Site selection is crucial for the success of rheumatology clinical trials due to the unique challenges associated with chronic diseases.
Key factors include:
Recruitment and retention: Selecting sites with a strong patient database ensures better recruitment and retention, especially for long-term studies
Expertise and experience: Sites with experience in rheumatology studies are more likely to deliver reliable and quality data
Regulatory compliance: Proper site selection helps meet regulatory standards and timelines, ensuring that the trial runs smoothly
Geographic diversity: It allows for the inclusion of diverse patient populations, which is important for evaluating the treatment’s efficacy across different demographics
Indero selects the most suitable sites by evaluating each site’s experience, recruitment capabilities, and performance in past trials. Indero’s process begins with a thorough pre-feasibility assessment, where we assess the site’s expertise, patient availability, and historical performance. We then use these data to create a tailored site selection strategy, considering factors like geographic location, regulatory requirements, and past recruitment success. Additionally, we maintain an investigator network and growing database of highly qualified sites, ensuring we can quickly identify and reach out to the most relevant sites for each specific study.
Indero’s established relationships with KOLs provide invaluable support throughout the site selection process:
Access to top sites: KOLs often have connections to leading clinical sites with high expertise and patient access
Enhanced recruitment: KOLs help us connect with sites that have a proven track record of successful patient recruitment and retention
Insight into site performance: KOLs provide additional insight into a site’s past performance, helping us make informed decisions about where to place studies
Faster site selection: With KOL endorsements, sites can be fast-tracked, streamlining the process and reducing study timelines
Key performance indicators (KPIs) for site selection in rheumatology trials are critical for ensuring that the study meets recruitment and data quality goals. These KPIs include historical recruitment rates, which highlight a site’s ability to enroll participants within the study’s time frame, and efficacy metrics, which evaluate how well a site has performed in previous trials. Other important KPIs are patient retention rates, site responsiveness, and regulatory compliance. These indicators help ensure that the sites selected will provide reliable data and meet study objectives efficiently.
Wherever
You’re Going,
We’re all in.
Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.
Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.
